BeOne Medicines AG (BVMF:B1ME34)

BeOne Medicines AG Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	28,739	19,178	22,491	26,689	27,797	9,022
Short-Term Investments	-	-	-	4,588	14,261	21,340
Cash & Short-Term Investments	28,739	19,178	22,491	31,278	42,058	30,362
Cash Growth	50.96%	-14.73%	-28.09%	-25.63%	38.52%	343.72%
Accounts Receivable	6,146	4,936	2,539	1,194	3,069	394.35
Other Receivables	278.35	239.61	268.45	178.06	108.39	125.81
Receivables	6,424	5,176	2,807	1,372	3,177	520.15
Inventory	3,785	3,613	2,951	1,947	1,541	582.96
Prepaid Expenses	208.83	360.33	625.83	573.1	881.82	376.93
Restricted Cash	377.23	67.97	81.35	1.35	2.08	2
Other Current Assets	791.82	740.22	850.02	742.45	707.15	541.92
Total Current Assets	40,327	29,135	29,806	35,914	48,368	32,386
Property, Plant & Equipment	12,589	12,538	10,065	6,593	4,479	2,927
Long-Term Investments	716.56	941.09	635.66	633.02	640.29	322.15
Goodwill	-	-	-	-	0.69	0.71
Other Intangible Assets	452.65	372.95	405.16	280.14	296.53	32.64
Long-Term Deferred Tax Assets	-	-	-	-	-	430.64
Other Long-Term Assets	253.05	230.34	253.27	578.75	438.51	466.04
Total Assets	54,338	43,217	41,165	43,999	54,223	36,565
Accounts Payable	2,731	2,956	2,234	2,033	1,667	1,514
Accrued Expenses	6,169	5,697	4,431	3,311	3,394	2,545
Short-Term Debt	5,468	5,963	4,678	2,171	2,698	2,185
Current Portion of Long-Term Debt	322.29	252.42	202.67	97.51	17.94	2
Current Portion of Leases	112	128.29	155.65	165.82	139.28	90.71
Current Income Taxes Payable	79.87	189.27	162.74	173.73	135.91	133.05
Current Unearned Revenue	371.94	-	-	1,475	1,191	-
Other Current Liabilities	1,607	980.93	970.18	700.7	918.13	549.73
Total Current Liabilities	16,861	16,167	12,835	10,129	10,161	7,020
Long-Term Debt	993.63	1,215	1,401	1,443	1,284	1,199
Long-Term Leases	365.83	323.18	157.78	238.07	273.42	192.05
Long-Term Unearned Revenue	6,136	221.34	242.54	553.17	1,694	320.81
Pension & Post-Retirement Benefits	121.34	119.74	106.33	53.52	49.64	52.97
Long-Term Deferred Tax Liabilities	335.07	306.61	116.96	110.33	90.01	70.46
Other Long-Term Liabilities	127.52	542.26	1,222	1,240	1,713	2,450
Total Liabilities	24,940	18,895	16,082	13,766	15,265	11,304
Common Stock	1.03	1.01	0.96	0.93	0.84	0.77
Additional Paid-In Capital	89,822	88,231	82,245	79,600	71,092	48,409
Retained Earnings	-59,704	-62,822	-56,458	-48,835	-32,249	-23,194
Comprehensive Income & Other	-720.87	-1,087	-705.16	-533.96	114.03	45.32
Total Common Equity	29,397	24,322	25,083	30,233	38,958	25,261
Shareholders' Equity	29,397	24,322	25,083	30,233	38,958	25,261
Total Liabilities & Equity	54,338	43,217	41,165	43,999	54,223	36,565
Total Debt	7,261	7,882	6,596	4,115	4,413	3,669
Net Cash (Debt)	21,478	11,296	15,895	27,162	37,645	26,694
Net Cash Growth	84.28%	-28.94%	-41.48%	-27.85%	41.03%	443.48%
Net Cash Per Share	192.96	107.28	152.27	263.37	405.73	319.79
Filing Date Shares Outstanding	110.66	106.72	104.58	104.32	102.68	91.6
Total Common Shares Outstanding	110.62	106.72	104.58	104.32	102.68	91.6
Working Capital	23,465	12,968	16,971	25,786	38,207	25,367
Book Value Per Share	265.75	227.91	239.85	289.81	379.42	275.77
Tangible Book Value	28,945	23,949	24,678	29,953	38,660	25,227
Tangible Book Value Per Share	261.66	224.41	235.97	287.13	376.52	275.40
Land	508.55	477.98	464.35	451.66	416	-
Buildings	8,311	4,437	1,643	1,534	915.3	728.12
Machinery	3,965	3,541	2,781	2,308	1,511	1,145
Construction In Progress	919.22	4,774	5,252	2,025	1,187	560.02
Leasehold Improvements	525.01	472.11	426.33	370.97	319.46	245.76

Source: S&P Global Market Intelligence. Standard template. Financial Sources.